Vivani Medical, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vivani Medical, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2015 to Q3 2024.
  • Vivani Medical, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $472.000.
  • Vivani Medical, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $1.85M.
  • Vivani Medical, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.86M, a 43.8% increase from 2022.
  • Vivani Medical, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.3M, a 22.3% decline from 2021.
  • Vivani Medical, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.67M, a 296% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.85M $472* -$39 Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.85M $383* -$141 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.85M $353K -$16K -4.34% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $1.86M $1.49M +$1.32M +774% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $541K $511* -$390K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $932K $524* -$393K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $1.33M $369K +$29K +8.53% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $1.3M $171K -$1.07M -86.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $2.37M $391K +$1K +0.26% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $2.36M $394K +$375K +1974% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $1.99M $340K +$321K +1689% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $1.67M $1.24M +$1.21M +4493% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $455K $390K +$363K +1344% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $92K $19K -$69K -78.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $161K $19K -$260K -93.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $421K $27K -$455K -94.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $876K $27K -$659K -96.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.54M $88K -$771K -89.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $2.31M $279K -$619K -68.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $2.93M $482K -$318K -39.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 $3.24M $686K -$191K -21.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $3.43M $859K +$232K +37% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $3.2M $898K -$387K -30.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-26
Q4 2018 $3.59M $800K -$163K -16.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 $3.75M $877K -$28K -3.09% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $3.78M $627K -$308K -32.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $4.09M $1.29M +$304K +31% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $3.78M $963K +$176K +22.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-19
Q3 2017 $3.61M $905K +$7K +0.78% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $3.6M $935K +$199K +27% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $3.4M $981K +$35K +3.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $3.37M $787K Oct 1, 2016 Dec 31, 2016 10-K 2019-03-19
Q3 2016 $898K +$42K +4.91% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $736K +$172K +30.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $946K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q3 2015 $856K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $564K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.